文献速递神经肌肉病

中老年轴索性神经病的遗传图景:聚焦MME基因

The genetic landscape of axonal neuropathies in the middle-aged and elderly: Focus on MME.
PubMed 文献 · Neurology · 2020-11-03

研究对230例起病年龄≥35岁的不明原因轴索性神经病患者进行遗传分析,其中126例接受全外显子测序、104例接受MME单基因测序,并查询外显子测序数据库、检测血中脑啡肽酶水平。外显子测序队列中假定致病变异的总体检出率为18.3%(家族性26.4%,散发性12.3%),MME最常见,占遗传学确诊案例的34.8%。结论认为部分不明原因晚发性轴索性神经病由遗传决定,MME变异既可表现为完全外显的隐性等位基因,也可在老龄人群中赋予显性遗传的轴索性神经病易感性。

要点

  • ≥35岁起病的不明原因轴索性神经病中,外显子测序的致病变异检出率为18.3%。
  • MME是检出最多的基因,占遗传学确诊案例的34.8%。
  • MME变异多呈不完全外显的常染色体显性遗传,少数呈隐性遗传。

核心结论

  • 部分不明原因晚发性轴索性神经病由遗传决定,涉及CMT基因或其他影响周围神经、可模拟CMT表型的疾病相关基因。
  • MME变异既可作为完全外显的隐性等位基因,也可在老龄人群中赋予显性遗传的轴索性神经病易感性。

研究设计与样本

  • 纳入230例起病年龄≥35岁的不明原因轴索性神经病患者,收集临床数据。
  • 对126例进行全外显子测序(WES),对104例进行MME单基因测序。
  • 查询WES数据库中的MME变异,并检测血中MME编码蛋白脑啡肽酶(neprilysin)水平。

主要发现

  • WES队列中CMT基因或其他神经病相关基因的假定致病变异总体检出率为18.3%,家族性病例为26.4%,貌似散发病例为12.3%。
  • MME最常受累,占遗传学确诊案例的34.8%。
  • 独立患者样本中检出相当比例的病例,患者中MME变异比例高于人群频率,WES数据库检索到更多携带MME变异的晚发性神经病患者,且患者血中脑啡肽酶水平低。
  • MME变异的传递常符合不完全外显的常染色体显性遗传,较少符合常染色体隐性遗传。

临床怎么用

  • 对≥35岁起病的不明原因轴索性神经病,可考虑遗传学检测,并将MME纳入分析。
  • MME变异携带者的遗传咨询需考虑不完全外显的显性遗传与隐性遗传两种模式。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To test the hypothesis that monogenic neuropathies such as Charcot-Marie-Tooth disease (CMT) contribute to frequent but often unexplained neuropathies in the elderly, we performed genetic analysis of 230 patients with unexplained axonal neuropathies and disease onset ≥35 years. METHODS: We recruited patients, collected clinical data, and conducted whole-exome sequencing (WES; n = 126) and MME single-gene sequencing (n = 104). We further queried WES repositories for MME variants and measured blood levels of the MME-encoded protein neprilysin. RESULTS: In the WES cohort, the overall detection rate for assumed disease-causing variants in genes for CMT or other conditions associated with neuropathies was 18.3% (familial cases 26.4%, apparently sporadic cases 12.3%). MME was most frequently involved and accounted for 34.8% of genetically solved cases. The relevance of MME for late-onset neuropathies was further supported by detection of a comparable proportion of cases in an independent patient sample, preponderance of MME variants among patients compared to population frequencies, retrieval of additional late-onset neuropathy patients with MME variants from WES repositories, and low neprilysin levels in patients' blood samples. Transmission of MME variants was often consistent with an incompletely penetrant autosomal-dominant trait and less frequently with autosomal-recessive inheritance. CONCLUSIONS: A detectable fraction of unexplained late-onset axonal neuropathies is genetically determined, by variants in either CMT genes or genes involved in other conditions that affect the peripheral nerves and can mimic a CMT phenotype. MME variants can act as completely penetrant recessive alleles but also confer dominantly inherited susceptibility to axonal neuropathies in an aging population.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Senderek J, Lassuthova P, Kabzińska D, et al. The genetic landscape of axonal neuropathies in the middle-aged and elderly: Focus on MME. Neurology. 2020. PMID: 33144514. doi:10.1212/WNL.0000000000011132

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。